$IBO Income Statement | Understand Stock

$IBO

$3.87 -$0.12 (3.01%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023
Revenue
Biotech Retail Sales
Total revenue
Costs and expenses:
Cost of revenue
Sales, general and administrative compensation (inclusive of stock-based compensation)
Sales and marketing
Professional Fees
Research and development
Other General Expenses
Depreciation and Amortization
Rent and utilities
Impairment of goodwill
Impairment of fixed assets
Loss on disposal of fixed assets
Other operating expenses
Total costs and expenses
Operating loss
Other income (expense):
Interest income
Other income
Change in fair value of note payable, related party
Interest expense
Loss from operations before income taxes
Income tax benefit (expense)
Net loss
Loss from operations attributed to noncontrolling interest
Net loss attributable to common stockholders
Earnings per common share:
Basic
Diluted
Shares used in computing loss per common share:
Basic
Diluted

Comments